The Global Synthetic Biology & Biomanufacturing Market 2026-2036

1             EXECUTIVE SUMMARY            63

• 1.1        Report Overview and Scope 63
  • 1.1.1    Report Scope and Coverage 63
  • 1.1.2    Analytical Framework              63
  • 1.1.3    Geographic Coverage               64
• 1.2        Definition and Scope of Industrial Biomanufacturing        64
  • 1.2.1    Defining Industrial Biomanufacturing           64
  • 1.2.2    Scope of Technologies Covered         64
  • 1.2.3    Market Boundaries    65
  • 1.2.4    Relationship to Adjacent Markets    65
• 1.3        Key Findings and Highlights 65
  • 1.3.1    Technology Advancement Has Dramatically Reduced Barriers    66
  • 1.3.2    Commercial Validation Continues to Expand          68
  • 1.3.3    Investment Momentum Remains Strong     68
  • 1.3.4    Sustainability Is Becoming a Competitive Advantage         69
  • 1.3.5    Scale-Up Remains the Critical Challenge   69
• 1.4        Global Market Size and Growth Projections 2026-2036    72
  • 1.4.1    Market Size Evolution               72
  • 1.4.2    Growth Drivers              74
  • 1.4.3    Growth Rate Analysis by Segment   75
• 1.5        Market Segmentation Overview         76
  • 1.5.1    Segmentation by Technology Platform          76
  • 1.5.2    Segmentation by Application Sector              77
  • 1.5.3    Segmentation by Product Type           78
  • 1.5.4    Segmentation by Geography               78
• 1.6        Technology Convergence: Synthetic Biology, Industrial Enzymes, and White Biotechnology   79
  • 1.6.1    Historical Separation of Markets       79
  • 1.6.2    Drivers of Convergence           79
  • 1.6.3    Implications for Market Analysis      82
  • 1.6.4    Competitive Implications      82
• 1.7        Major Trends and Growth Drivers      83
  • 1.7.1    Sustainability Mandates         83
  • 1.7.2    Technology Cost Reduction 84
  • 1.7.3    Scale-Up Success      85
  • 1.7.4    AI/ML Integration         85
  • 1.7.5    Consumer Demand   89
• 1.8        Investment Landscape and Funding Trends              90
  • 1.8.1    Venture Capital Investment  90
  • 1.8.2    Corporate Strategic Investment         92
  • 1.8.3    Government Funding                92
  • 1.8.4    Investment Focus Areas         94
• 1.9        Technology Roadmap 2026-2036    95
  • 1.9.1    Near-Term Developments (2026-2028)        95
  • 1.9.2    Mid-Term Developments (2029-2032)          97
  • 1.9.3    Long-Term Vision (2033-2036)           98
• 1.10     Value Chain Analysis 100
  • 1.10.1 Feedstock Supply       102
  • 1.10.2 Technology and Intellectual Property             103
  • 1.10.3 Production and Manufacturing          103
  • 1.10.4 Distribution and End-Users  105
  • 1.10.5 Value Capture Analysis           105
• 1.11     Colours of Biotechnology      106
  • 1.11.1 Red Biotechnology (Medical/Pharmaceutical)        107
  • 1.11.2 White Biotechnology (Industrial)      107
  • 1.11.3 Green Biotechnology (Agricultural) 108
  • 1.11.4 Blue Biotechnology (Marine)               109
  • 1.11.5 Yellow Biotechnology (Food)               110
  • 1.11.6 Grey Biotechnology (Environmental)             110
  • 1.11.7 Gold Biotechnology (Bioinformatics/Computational)        110
  • 1.11.8 Report Focus 111

2             INTRODUCTION TO BIOMANUFACTURING               112

• 2.1        Definition of Synthetic Biology and Biomanufacturing      112
  • 2.1.1    Foundational Principles of Synthetic Biology           112
  • 2.1.2    Genetic Circuits and Metabolic Engineering             112
  • 2.1.3    Definition of Biomanufacturing         113
• 2.2        Difference Between Synthetic Biology and Genetic Engineering 114
  • 2.2.1    Traditional Genetic Engineering         114
  • 2.2.2    Synthetic Biology Approach 115
  • 2.2.3    Practical Implications              116
• 2.3        Historical Evolution of Industrial Biotechnology     117
  • 2.3.1    Traditional Fermentation Era (Pre-1970s)    118
  • 2.3.2    Recombinant DNA Era (1970s-1990s)          118
  • 2.3.3    Genomics and Systems Biology Era (1990s-2000s)            119
  • 2.3.4    Synthetic Biology Era (2000s-Present)          120
  • 2.3.5    AI Integration Era (2020s-Future)      120
• 2.4        Key Components of Industrial Biomanufacturing 121
  • 2.4.1    Strain Engineering      122
  • 2.4.2    Fermentation and Cell Culture           123
  • 2.4.3    Downstream Processing        127
  • 2.4.4    Process Analytical Technology (PAT)              132
  • 2.4.5    Quality Control and Assurance         132
• 2.5        Comparison with Conventional Chemical Processes         136
  • 2.5.1    Selectivity and Stereochemistry        136
  • 2.5.2    Complex Molecule Synthesis              137
  • 2.5.3    Reaction Conditions 140
  • 2.5.4    Feedstock and Sustainability             140
  • 2.5.5    Limitations of Biomanufacturing      141
  • 2.5.6    Hybrid Processes        144
• 2.6        Importance in the Global Economy 145
  • 2.6.1    Role in Healthcare and Pharmaceuticals   145
  • 2.6.2    Biopharmaceutical Market Scale     145
  • 2.6.3    Manufacturing Complexity   146
    • 2.6.3.1 Emerging Modalities 147
• 2.6.4    Impact on Industrial Sustainability 148
  • 2.6.4.1 Carbon Footprint Reduction                148
  • 2.6.4.2 Resource Efficiency   148
  • 2.6.4.3 Corporate and Regulatory Drivers    148
• 2.6.5    Food Security Applications  149
  • 2.6.5.1 Alternative Proteins   149
  • 2.6.5.2 Agricultural Biotechnology   153
  • 2.6.5.3 Food Ingredients          153
• 2.6.6    Circular Economy Integration             153
  • 2.6.6.1 Waste Valorization     153
  • 2.6.6.2 Enzymatic Recycling 156
  • 2.6.6.3 Biodegradable Materials        156
• 2.7        Sustainability Benefits and Environmental Impact               156
  • 2.7.1    Life Cycle Assessment Framework  156
  • 2.7.2    Emissions        158
  • 2.7.3    Energy Consumption               159
  • 2.7.4    Water Use        159
  • 2.7.5    Land Use          163
  • 2.7.6    Toxicity and Environmental Release               163

3             TECHNOLOGY ANALYSIS       164

• 3.1        Biomanufacturing Processes Overview        164
  • 3.1.1    Batch Production        166
  • 3.1.2    Fed-Batch Production              166
  • 3.1.3    Continuous Production           167
  • 3.1.4    Perfusion Culture        169
• 3.2        Production Systems  170
  • 3.2.1    Bacterial Systems       170
  • 3.2.2    Yeast Systems               170
  • 3.2.3    Mammalian Cell Culture        170
  • 3.2.4    Other Production Systems    171
• 3.3        Precision Fermentation           171
  • 3.3.1    Technology Overview and Principles              171
  • 3.3.2    Production Methods and Scale-Up 172
  • 3.3.3    Commercial Applications     177
    • 3.3.3.1 Alternative Proteins   177
    • 3.3.3.2 Specialty Ingredients                177
  • 3.3.4    Market Outlook            177
• 3.4        Cell-Free Systems      179
  • 3.4.1    Technology Overview                179
  • 3.4.2    Advantages Over Cell-Based Systems          180
  • 3.4.3    Commercial Applications     180
  • 3.4.4    Market Outlook            180
• 3.5        AI-Designed Enzymes and Computational Biology               182
  • 3.5.1    Computational Enzyme Design         183
  • 3.5.2    Machine Learning Integration              183
  • 3.5.3    Traditional vs AI-Driven Development            184
• 3.6        Cell Factories for Biomanufacturing              184
  • 3.6.1    Established Chassis Organisms       186
  • 3.6.2    Emerging and Specialized Organisms           188
• 3.7        Supporting Technologies        193
  • 3.7.1    DNA Synthesis and Gene Assembly               193
  • 3.7.2    Genome Editing Technologies            194
  • 3.7.3    Metabolic Engineering             196
  • 3.7.4    Protein Engineering    196
• 3.8        Upstream Processing               199
  • 3.8.1    Bioreactor Systems   199
  • 3.8.2    Process Analytical Technology (PAT)              200
• 3.9        Downstream Processing        200
  • 3.9.1    Primary Recovery        200
  • 3.9.2    Purification Technologies       200
  • 3.9.3    Formulation    201
• 3.10     Alternative Feedstocks and Sustainability 201
  • 3.10.1 Traditional Feedstocks            201
  • 3.10.2 C1 Feedstocks              201
  • 3.10.3 Lignocellulosic Biomass        203
  • 3.10.4 Waste Stream Valorization   204
  • 3.10.5 Carbon Capture Integration 205
• 3.11     Technology Outlook and Implications           208

4             INDUSTRIAL ENZYMES AND BIOCATALYSTS             210

• 4.1        Overview and Classification 210
  • 4.1.1    Bio-Manufactured Enzymes 211
  • 4.1.2    Enzyme Types and Functions              211
    • 4.1.2.1 Carbohydrases             212
    • 4.1.2.2 Proteases         212
    • 4.1.2.3 Lipases              213
    • 4.1.2.4 Amylases         213
    • 4.1.2.5 Oxidoreductases         214
• 4.2        Technology and Materials Analysis 214
  • 4.2.1    Detergent Enzymes    214
  • 4.2.2    Food Processing Enzymes    216
  • 4.2.3    Textile Processing Enzymes  218
  • 4.2.4    Paper and Pulp Enzymes        219
  • 4.2.5    Leather Processing Enzymes               220
  • 4.2.6    Biofuel Production Enzymes                221
    • 4.2.6.1 Cellulases for Lignocellulosic Bioethanol  222
    • 4.2.6.2 Hemicellulases and Synergistic Cocktails 225
    • 4.2.6.3 Thermostable and Extremophilic Enzymes                226
  • 4.2.7    Animal Feed Enzymes              227
  • 4.2.8    Pharmaceutical and Diagnostic Enzymes  228
  • 4.2.9    Waste Management and Bioremediation Enzymes              229
    • 4.2.9.1 Enzymes for Plastics Recycling          230
    • 4.2.9.2 Enzymatic Depolymerization               231
  • 4.2.10 Agriculture and Crop Improvement Enzymes           233
  • 4.2.11 Enzymes for Decarbonization and CO₂ Utilization 235
    • 4.2.11.1            Carbonic Anhydrase in CO₂ Capture              235
    • 4.2.11.2            Formate Dehydrogenase Pathways 236
• 4.3        Production Methods 237
  • 4.3.1    Extraction from Natural Sources       237
  • 4.3.2    Microbial Fermentation Production 238
  • 4.3.3    Genetically Engineered Organisms 238
  • 4.3.4    Cell-Free Systems Production            238
  • 4.3.5    Immobilized Enzyme Systems            239
• 4.4        Market Analysis           240
  • 4.4.1    Key Players and Competitive Landscape    240
  • 4.4.2    Market Growth Drivers and Trends   240
  • 4.4.3    Technology Challenges and Opportunities 241
  • 4.4.4    Economic Competitiveness Analysis            242
  • 4.4.5    Pricing Dynamics        243
  • 4.4.6    Regulatory Landscape             243
  • 4.4.7    Value Chain Analysis 244
  • 4.4.8    Risks and Opportunities         245

5             END-USE MARKETS AND APPLICATIONS    248

• 5.1        Biopharmaceuticals and Healthcare             248
  • 5.1.1    Monoclonal Antibodies (mAbs)         252
  • 5.1.2    Recombinant Proteins             261
  • 5.1.3    Vaccines           265
  • 5.1.4    Cell and Gene Therapies        269
  • 5.1.5    Blood Factors 273
  • 5.1.6    Nucleic Acid Therapeutics    275
  • 5.1.7    Peptide Therapeutics               278
  • 5.1.8    Biosimilars and Biobetters    280
  • 5.1.9    Nanobodies and Antibody Fragments           282
  • 5.1.10 Tissue Engineering Products                283
  • 5.1.11 Drug Discovery and Personalized Medicine               284
  • 5.1.12 Biopharmaceuticals Regulations     286
  • 5.1.13 Market Analysis and Outlook              287
    • 5.1.13.1            Value Chain    292
    • 5.1.13.2            Market Growth Drivers and Trends   294
    • 5.1.13.3            Key players      295
• 5.2        Agriculture and Food 296
  • 5.2.1    Alternative Proteins   297
    • 5.2.1.1 Precision Fermentation for Food Proteins   298
    • 5.2.1.2 Cultivated Meat            300
    • 5.2.1.3 Microbial Protein (Single-Cell Protein)          302
  • 5.2.2    Food Ingredients          303
    • 5.2.2.1 Natural Flavours and Fragrances      303
    • 5.2.2.2 Natural Sweeteners   304
    • 5.2.2.3 Food Colourants and Other Ingredients       305
  • 5.2.3    Agricultural Biologicals           305
    • 5.2.3.1 Biofertilizers   305
    • 5.2.3.2 Biopesticides 306
    • 5.2.3.3 Biostimulants 308
  • 5.2.4    Feed Additives and Animal Nutrition              309
  • 5.2.5    Crop Improvement and Gene Editing             309
  • 5.2.6    Market Analysis and Outlook              310
    • 5.2.6.1 Key players      310
• 5.3        Biochemicals 311
  • 5.3.1    Organic Acids 313
    • 5.3.1.1 Lactic Acid       313
    • 5.3.1.2 Succinic Acid 314
    • 5.3.1.3 Citric Acid        316
    • 5.3.1.4 Other Organic Acids  317
  • 5.3.2    Platform Chemicals and Diols            317
    • 5.3.2.1 1,3-Propanediol (1,3-PDO)   317
    • 5.3.2.2 1,4-Butanediol (BDO)              318
  • 5.3.3    Alcohols and Solvents             319
    • 5.3.3.1 Bioethanol       319
    • 5.3.3.2 Isobutanol       320
    • 5.3.3.3 n-Butanol         320
  • 5.3.4    Amino Acids   320
    • 5.3.4.1 L-Glutamate   321
    • 5.3.4.2 L-Lysine             321
    • 5.3.4.3 Other Amino Acids     321
  • 5.3.5    Biosurfactants              322
  • 5.3.5.1 Rhamnolipids 322
  • 5.3.5.2 Sophorolipids                323
  • 5.3.5.3 Mannosylerythritol Lipids (MELs)     324
  • 5.3.6    Vitamins and Nutraceuticals               324
  • 5.3.7    Specialty Chemicals and Polymer Intermediates  325
    • 5.3.7.1 Polybutylene Succinate (PBS) Intermediates            325
    • 5.3.7.2 Polyethylene Furanoate (PEF) Intermediates            325
  • 5.3.8    Gas Fermentation and C1 Chemicals           326
  • 5.3.9    Market Analysis and Outlook              326
    • 5.3.9.1 Key players      326
• 5.4        Bioplastics      328
  • 5.4.1    Polylactic Acid (PLA) 333
  • 5.4.2    Polyhydroxyalkanoates (PHAs)          336
  • 5.4.3    Bio-based Polyethylene (Bio-PE)      339
  • 5.4.4    Bio-based PET               339
  • 5.4.5    Polybutylene Succinate (PBS)            340
  • 5.4.6    Starch-based Plastics              341
  • 5.4.7    PBAT (Polybutylene Adipate Terephthalate)                342
  • 5.4.8    Polyethylene Furanoate (PEF)             343
  • 5.4.9    Bio-based Polyamides (Nylons)        343
  • 5.4.10 Cellulose-Based Bioplastics.             344
  • 5.4.11 Emerging Bioplastic Technologies   345
    • 5.4.11.1            Mycelium-based Materials   346
    • 5.4.11.2            Algae-based Plastics 346
  • 5.4.12 Bioplastic Blends and Compounds 346
  • 5.4.13 Bioplastics End-of-Life Options        348
  • 5.4.14 Market Analysis and Outlook              349
    • 5.4.14.1            Market Growth Drivers and Trends   349
    • 5.4.14.2            Value Chain    350
    • 5.4.14.3            Addressable Market Size        351
    • 5.4.14.4            Risks and Opportunities in Bioplastics         352
  • 5.4.15 Global Revenues for Bioplastics by Type 2020-2036          353
    • 5.4.15.1            Bioplastics Regulations          355
    • 5.4.15.2            Key players      356
• 5.5        Biofuels             356
  • 5.5.1    Biofuel Feedstocks    359
  • 5.5.2    Bioethanol       363
    • 5.5.2.1 First-Generation Bioethanol 363
    • 5.5.2.2 Second-Generation (Cellulosic) Bioethanol             364
  • 5.5.3    Biodiesel           368
  • 5.5.4    Renewable Diesel (HVO)        373
  • 5.5.5    Sustainable Aviation Fuel (SAF)         378
  • 5.5.6    Gas Fermentation       382
  • 5.5.7    Biogas and Biomethane         383
    • 5.5.7.1 Anaerobic Digestion 384
    • 5.5.7.2 Biomass Gasification               384
    • 5.5.7.3 Power-to-Methane      384
  • 5.5.8    Biochar and Bio-oil    388
  • 5.5.9    Biobutanol      394
  • 5.5.10 Algal Biofuels 394
  • 5.5.11 Future Trends in Biofuels       397
  • 5.5.12 Market Analysis and Outlook              397
    • 5.5.12.1            Market Growth Drivers             401
    • 5.5.12.2            Biofuels Regulations 402
    • 5.5.12.3            Value Chain    403
    • 5.5.12.4            Key players      404
• 5.6        Environmental Applications 405
  • 5.6.1    Market Overview          405
  • 5.6.2    Bioremediation Technologies              406
  • 5.6.3    Wastewater Treatment             409
  • 5.6.4    Plastic Biodegradation            412
  • 5.6.5    Carbon Capture and Utilization         416
  • 5.6.6    Air Biotreatment           421
  • 5.6.7    Value Chain Analysis 423
  • 5.6.8    Regulatory Landscape             424
  • 5.6.9    Key Players      425
  • 5.6.10 Market Trends and Drivers     426
  • 5.6.11 Future Outlook             427
• 5.7        Consumer Goods       428
  • 5.7.1    Market Overview          428
  • 5.7.2    Personal Care and Cosmetics            429
  • 5.7.3    Home Care and Cleaning Products 432
  • 5.7.4    Fragrances and Flavours        435
  • 5.7.5    Textiles and Fashion 438
  • 5.7.6    Value Chain Analysis 440
  • 5.7.7    Regulations and Certifications           441
  • 5.7.8    Key Players      442
  • 5.7.9    Market Drivers and Trends     442
  • 5.7.10 Future Outlook             443

6             GLOBAL MARKET REVENUES AND FORECASTS     445

• 6.1        Industrial Biomanufacturing Market Overview         445
  • 6.1.1    Total Addressable Market 2026-2036            445
  • 6.1.2    Market Integration and Overlaps       447
  • 6.1.3    Technology Convergence Drivers      448
    • 6.1.3.1 Cost Reduction Drivers           448
    • 6.1.3.2 Precision Engineering Capabilities  448
    • 6.1.3.3 AI Integration  448
• 6.2        Market by Technology Platform          449
  • 6.2.1    Synthetic Biology Technologies         449
  • 6.2.2    Precision Fermentation           451
  • 6.2.3    Cell-Free Systems      452
  • 6.2.4    AI and Computational Biology Platforms     453
  • 6.2.5    Traditional Fermentation Systems   454
  • 6.2.6    Technology Platform Comparison   456
• 6.3        Market by Application Sector               457
  • 6.3.1    Biopharmaceuticals 457
    • 6.3.1.1 Market Overview and Global Revenues 2020-2036             457
    • 6.3.1.2 Market Segmentation by Product Type          458
    • 6.3.1.3 Regional Market Analysis      459
  • 6.3.2    Industrial Enzymes and Biocatalysts             460
    • 6.3.2.1 Market Overview and Global Revenues 2020-2036             460
    • 6.3.2.2 Market Segmentation by Enzyme Type          461
    • 6.3.2.3 Market Segmentation by Source       462
  • 6.3.3    Biofuels             463
    • 6.3.3.1 Market Overview and Global Revenues 2020-2036             463
    • 6.3.3.2 Market Segmentation by Application             464
    • 6.3.3.3 Regional Market Analysis      465
  • 6.3.4    Bioplastics and Biomaterials              466
    • 6.3.4.1 Market Overview and Global Revenues 2020-2036             466
    • 6.3.4.2 Material Type Analysis             467
    • 6.3.4.3 Application Market Analysis 468
    • 6.3.4.4 Regional Market Analysis      470
  • 6.3.5    Biochemicals 470
    • 6.3.5.1 Market Overview and Global Revenues 2020-2036             470
    • 6.3.5.2 Application Market Analysis 472
    • 6.3.5.3 Regional Market Analysis      473
  • 6.3.6    Bio-Agritech    473
    • 6.3.6.1 Market Overview and Global Revenues 2020-2036             473
    • 6.3.6.2 Regional Market Analysis      475
• 6.4        Market by Product Type           475
  • 6.4.1    Synthetic Biology Products   475
• 6.5        Market by Region         476
  • 6.5.1    North America              476
  • 6.5.2    Europe                476
  • 6.5.3    Asia-Pacific    476
  • 6.5.4    Rest of World 477
• 6.6        Investment and Funding Analysis    478
  • 6.6.1    Venture Capital Trends            478
  • 6.6.2    Corporate Investment              478
  • 6.6.3    Government Funding Programs        479

7             MARKET ANALYSIS      480

• 7.1        SWOT Analysis             480
  • 7.1.1    Industrial Biomanufacturing SWOT 480
  • 7.1.2    Precision Fermentation SWOT            481
  • 7.1.3    Cell-Free Systems SWOT       483
  • 7.1.4    AI-Designed Enzymes SWOT               485
• 7.2        Porter's Five Forces Analysis               486
• 7.3        Value Chain Analysis 488
  • 7.3.1    Feedstock Suppliers 488
    • 7.3.1.1 Primary Feedstock Categories           488
    • 7.3.1.2 Production and Manufacturing          489
  • 7.3.2    Distribution and End-Users  490
    • 7.3.2.1 Distribution Models   490
    • 7.3.2.2 End-User Segments  491
  • 7.3.3    Economic Viability Factors   491
    • 7.3.3.1 Cost Structure Components               491
  • 7.3.4    Scale-Up Cost Analysis          492
    • 7.3.4.1 Scale-Up Economics                492
• 7.4        Competitive Landscape and Market Map   493
  • 7.4.1    Market Map by Category         493
  • 7.4.2    Competitive Positioning         494
    • 7.4.2.1 Positioning Dimensions         494
  • 7.4.3    Strategic Groups Analysis     495
• 7.5        Technology Readiness Levels (TRL) 496
  • 7.5.1    Biopharmaceuticals TRL        496
  • 7.5.2    Industrial Enzymes TRL           496
  • 7.5.3    Biofuels TRL   497
  • 7.5.4    Bioplastics TRL             498
  • 7.5.5    Biochemicals TRL       499
• 7.6        Regulatory Landscape             500
  • 7.6.1    United States Regulations     500
  • 7.6.2    European Union Regulations               501
  • 7.6.3    Asia-Pacific Regulations        502
  • 7.6.4    International Standards          503
    • 7.6.4.1 Key International Bodies        503
  • 7.6.5    Biosafety and Biosecurity      504
• 7.7        Industry Challenges  506
  • 7.7.1    Production Cost Challenges                506
  • 7.7.2    Scale-Up Barriers        508
  • 7.7.3    Public Perception        509
  • 7.7.4    Technical Challenges               509
  • 7.7.5    Feedstock Price Impacts       510
• 7.8        Government Support and Policy       512
  • 7.8.1    US Bioeconomy Initiatives    512
  • 7.8.2    EU Green Deal and Bioeconomy Strategy   513
  • 7.8.3    China Biotechnology Policy  514
  • 7.8.4    Carbon Tax Implications         515

8             COMPANY PROFILES                517 (915 company profiles)

9             REFERENCES 1131

List of Tables

• Table 1. Scope of Industrial Biomanufacturing Technologies.       65
• Table 2. DNA Synthesis Cost Decline 2000-2024  66
• Table 3. Advanced Technologies in Biomanufacturing Applications.       66
• Table 4. Key Market Metrics and Growth Projections 2026-2036.               68
• Table 5. Global Synthetic Biology Market by Technology Segment 2026-2036 (USD Billion).   72
• Table 6. Global Synthetic Biology Market Growth 2020-2036        74
• Table 7. Market Segmentation by Technology Platform 2026 vs 2036       76
• Table 8. Market Segmentation by Application Sector 2026-2036 77
• Table 9. Global Market Share by Region 2026 vs 2036        78
• Table 10. AI and Robotics Applications in Biomanufacturing.       81
• Table 11. Technology Convergence Examples Across Traditional Market Boundaries. 82
• Table 12. Regulatory Drivers for Bio-Based Products by Region   83
• Table 13. Technology Cost Reduction Trends 2000-2036 85
• Table 14. AI/ML Applications in Biomanufacturing Systems.         85
• Table 15. Major Trends and Growth Drivers Summary        89
• Table 16. Venture Capital Investment in Synthetic Biology 2015-2024   91
• Table 17. Major Synthetic Biology Funding Rounds 2023-2024]  91
• Table 18. Government Biotechnology Funding by Region 93
• Table 19. Investment Focus Areas and Key Companies]  95
• Table 20. Feedstock Types and Characteristics      102
• Table 21.Production Cost Breakdown by Product Category            103
• Table 22. Value Chain Position and Value Capture                105
• Table 23. Colours of Biotechnology Classification                106
• Table 24. White Biotechnology Fermentation Processes. 107
• Table 25. Blue Biotechnology Feedstock Characteristics and Applications.       109
• Table 26. Genetic Circuit Components and Functions       113
• Table 27. Comparison of Genetic Engineering and Synthetic Biology Approaches          115
• Table 28.Biomanufacturing Revolutions and Representative Products. 117
• Table 29. Key Milestones in Recombinant DNA Era              119
• Table 30. Industrial Biotechnology Eras and Characteristics         120
• Table 31. Key Components of Industrial Biomanufacturing.          121
• Table 32. Strain Engineering Approaches and Tools             123
• Table 33. Types of Cell Culture Systems.     123
• Table 34. Factors Affecting Cell Culture Performance.      125
• Table 35. Advances in Fermentation Technology.   126
• Table 36.Types of Purification Methods in Downstream Processing.        127
• Table 37. Downstream Processing Unit Operations             129
• Table 38. Factors Affecting Purification Performance.        129
• Table 39. Downstream Processing Technology Improvements.    131
• Table 40. Types of Quality Control Tests in Biomanufacturing.     132
• Table 41. Common Formulation Methods Used in Biomanufacturing.   134
• Table 42. Comparison of Biomanufacturing and Chemical Synthesis     136
• Table 43. Complexity Comparison—Chemical vs Biological Synthesis Routes 137
• Table 44. Environmental Comparison—Selected Bio-Based vs Petrochemical Products]         141
• Table 45. Synthesis Route Comparison by Product Category.       141
• Table 46. Advances in Formulation Technology.     143
• Table 47. Hybrid Biotechnological-Chemical Process Applications.        144
• Table 48. Biopharmaceutical Market by Category 146
• Table 49. Sustainability Drivers and Bio-Based Responses            149
• Table 50. Alternative Protein Market Projections    153
• Table 51. Waste Valorization Pathways in Biomanufacturing         154
• Table 52. Circular Economy Integration Examples 156
• Table 53. GHG Emissions Comparison—Bio-Based vs Conventional Products 159
• Table 54. Water Use in Biomanufacturing vs Chemical Processes             161
• Table 55. Environmental Impact Summary—Bio-Based Production Advantages             163
• Table 56. Process Mode Selection Decision Framework   165
• Table 57. Batch Production Characteristics              166
• Table 58.Continuous vs Batch Biomanufacturing Comparison.  168
• Table 59. Production Mode Comparison Summary              169
• Table 60. Production System Comparison 171
• Table 61. Factors Affecting Scale-up Performance in Biomanufacturing.             173
• Table 62. Scale-up Strategies in Biomanufacturing.            174
• Table 63. Precision Fermentation Strain Development Pipeline   175
• Table 64. Precision Fermentation Companies and Products          177
• Table 65. Precision Fermentation Market by Application 2024-2036 (USD Billion)          178
• Table 66. Cell-Free Systems Market by Application 2024-2036 (USD Billion)      180
• Table 67. Machine Learning Applications in Biomanufacturing.  182
• Table 68. Development Approach Comparison      184
• Table 69. Major Microbial Cell Factories Used in Industrial Biomanufacturing. 184
• Table 70. Organism Categories and Production Capabilities.       186
• Table 71. E. coli Characteristics for Biomanufacturing Applications.      187
• Table 72. Chassis Organism Comparison  188
• Table 73. C. glutamicum Production Capabilities and Characteristics.  188
• Table 74. B. subtilis Production Systems and Applications.           189
• Table 75. S. cerevisiae Capabilities and Industrial Applications. 190
• Table 76. Y. lipolytica Production Capabilities and Process Parameters.               191
• Table 77. Non-Model Organisms and Specialized Applications. 192
• Table 78. DNA Synthesis Technologies and Capabilities. 194
• Table 79. CRISPR-Cas9 Applications in Biomanufacturing.           195
• Table 80. Protein Engineering Strategies and Applications.             197
• Table 81. Computer-Aided Design Tools in Biotechnology.              198
• Table 82. C1 Feedstock Utilization Pathways and Characteristics.            201
• Table 83. C2 Feedstock Processing and Applications.       202
• Table 84. Lignocellulosic Feedstock Characteristics          203
• Table 85. Lignocellulosic Biomass Processing Technologies.        203
• Table 86. Automation Applications in Biotechnology.         208
• Table 87. Types of Industrial Enzymes.         210
• Table 88. EC Classification of Industrial Enzymes.               211
• Table 89. Industrial Enzyme Types and Applications.          214
• Table 90.Types of Detergent Enzymes.          215
• Table 91. Types of Food Processing Enzymes.         216
• Table 92. Food Processing Enzyme Applications.  218
• Table 93. Types of Textile Processing Enzymes.      219
• Table 94. Types of Paper and Pulp Processing Enzymes.  220
• Table 95. Types of Leather Processing Enzymes.   220
• Table 96. Biofuel Enzyme Requirements and Performance.           221
• Table 97. Types of Biofuel Production Enzymes.     222
• Table 98. Lignocellulosic Enzyme Systems and Performance.      223
• Table 99. Cellulase Component Functions and Characteristics. 224
• Table 100. Hemicellulase Systems and Substrate Specificity.      225
• Table 101. Thermostable Enzyme Sources and Characteristics. 226
• Table 102. Types of Animal Feed Enzymes. 227
• Table 103. Types of Pharmaceutical and Diagnostic Enzymes.    228
• Table 104. Types of Waste Management and Bioremediation Enzymes. 229
• Table 105. Enzymes for Plastics Recycling Applications.  230
• Table 106. Enzymatic Plastic Recycling Development Status.       231
• Table 107. Challenges in Enzymatic Depolymerization.     232
• Table 108. Types of Agriculture and Crop Improvement Enzymes.             233
• Table 109. Comparison of Enzyme Types.   234
• Table 110. Enzymes for Decarbonization and CO₂ Utilization.      235
• Table 111. Carbonic Anhydrase Applications in CO₂ Capture.      236
• Table 112. Formate Dehydrogenase Systems for CO₂ Conversion.            237
• Table 113. Immobilized Enzyme Systems and Applications.          239
• Table 114. Market Growth Drivers and Trends in Industrial Enzymes.       240
• Table 115. Technology Challenges and Opportunities for Industrial Enzymes.  241
• Table 116. Industrial Enzymes Regulations.              243
• Table 117. Value Chain: Industrial Enzymes.            244
• Table 118. Industrial Enzyme Market Forecast by Application 2024-2036 (USD Billion).             245
• Table 119. Types of Biopharmaceuticals.   248
• Table 120. Types of biopharmaceuticals.   250
• Table 121. Technology Readiness Level (TRL): Biopharmaceuticals.       251
• Table 122. Types of Monoclonal Antibodies.             253
• Table 123. Host organisms commonly used in biopharmaceutical manufacturing.      256
• Table 124. Cell Line Development Platform Comparison.               257
• Table 125. Advances in Purification Technology.    259
• Table 126. Key players in monoclonal antibodies. 260
• Table 127. Types of Recombinant Proteins.               263
• Table 128. Types of biopharma vaccines.   265
• Table 129. Companies involved in synthetic biology for vaccine production.     267
• Table 130. Types of Cell and Gene Therapies.          269
• Table 131. Companies involved in synthetic biology for gene therapy and regenerative medicine.       271
• Table 132. Types of Blood Factors.  273
• Table 133. Types of Nucleic Acid Therapeutics.      275
• Table 134. Types of Peptide Therapeutics. 278
• Table 135. Types of Biosimilars and Biobetters.      280
• Table 136. Types of Nanobodies and Antibody Fragments.             282
• Table 137. Types of Tissue Engineering Products.  283
• Table 138. Companies involved in synthetic biology for gene therapy and regenerative medicine.       285
• Table 139. Risks and Opportunities in biopharmaceuticals.          286
• Table 140. Biopharmaceuticals Regulations.           287
• Table 141. Addressable market size for biopharmaceuticals.       289
• Table 142. Global revenues for biopharmaceuticals, by applications market (2020-2036), billions USD.                289
• Table 143. Global revenues for biopharmaceuticals, by regional market (2020-2036), billions USD. 290
• Table 144. Risks and Opportunities in Biopharmaceuticals.         291
• Table 145. Biopharmaceutical Manufacturing Value Chain: Detailed Overview.               292
• Table 146. Market Growth Drivers and Trends in Biopharmaceuticals.   294
• Table 147. Key players in biopharmaceuticals.       295
• Table 148. Risks and Opportunities in Agriculture and Food Biotechnology.       296
• Table 149. Alternative protein production approaches.     297
• Table 150. Companies developing precision fermentation-derived food proteins.         299
• Table 151. Companies developing cultivated meat.             300
• Table 152. Companies developing microbial biomass proteins. 303
• Table 153. Biofertilizer companies and products.  306
• Table 154. Main types of biopesticides.       306
• Table 155. Biopesticides companies and products.            307
• Table 156. Biostimulants companies and products.           308
• Table 157. Agriculture and food biotechnology market summary.             310
• Table 158. Key players in agriculture and food biotechnology.      310
• Table 159. Technology Readiness Levels for biochemicals.            311
• Table 160. Types of biochemicals produced through biomanufacturing.              312
• Table 161. Lactic acid applications and market segments.            314
• Table 162. Leading lactic acid and PLA producers.               314
• Table 163. Biobased feedstock sources for succinic acid production.    315
• Table 164. Applications of succinic acid.    316
• Table 165. Applications of bio-based 1,3-Propanediol.     317
• Table 166. Applications of bio-based 1,4-Butanediol.       318
• Table 167. Key molecules for biobased synthetic polymers.          319
• Table 168. Applications of bio-based isobutanol. 320
• Table 169. Major amino acid production volumes and applications.        321
• Table 170. Types of biosurfactants. 322
• Table 171. Rhamnolipid production and application characteristics.      323
• Table 172. Sophorolipid types and application properties.              323
• Table 173. Applications of biosurfactants. 324
• Table 174. PBS market analysis.       325
• Table 175. Biochemicals market summary by segment.   326
• Table 176. Key players in biochemicals.      326
• Table 177. Risks and Opportunities in Biochemicals.         327
• Table 178. Technology Readiness Levels for bioplastics. 328
• Table 179. Classification of Bioplastics.      329
• Table 180. Risks and Opportunities in Bioplastics.              330
• Table 181. Types of bioplastics.        330
• Table 182. Properties of Bioplastics Compared to Conventional Plastics.           332
• Table 183. Bioplastics and bioplastic precursors synthesized via biotechnology processes.  332
• Table 184. PLA Properties and Grades.         333
• Table 185. PLA market analysis—manufacture, advantages, disadvantages, and applications.           334
• Table 186. PLA producers and production capacities.       335
• Table 187. Types of PHAs and properties.   336
• Table 188. Commercially available PHAs.  337
• Table 189. PHA producers and capacities. 338
• Table 190. PBS market analysis—manufacture, advantages, disadvantages, and applications.          340
• Table 191. PBS and PBAT Properties.              340
• Table 192. Leading PBS producers and production capacities.   341
• Table 193. Starch-Based Bioplastics.            342
• Table 194. Bio-Polyamides (Bio-PA).              343
• Table 195. Cellulose-Based Bioplastics.     344
• Table 196. Emerging Bioplastics.     345
• Table 197. Types of polymer blends with bio-based components.             347
• Table 198. Bioplastics Processing Technologies.   347
• Table 199. Bioplastics End-of-Life Options.              348
• Table 200. Market Growth Drivers and Trends in Bioplastics.        349
• Table 201. Value Chain: Bioplastics.              350
• Table 202. Addressable Market Size for Bioplastics.           351
• Table 203. Risks and Opportunities in Bioplastics.              352
• Table 204. Global Revenues for Bioplastics by Type 2020-2036. 353
• Table 205. Global Revenues for Bioplastics by Applications Market 2020-2036.             354
• Table 206. Bioplastics Regulations. 355
• Table 207. Key players in bioplastics.            356
• Table 208. Types of Biofuel by Generation. 356
• Table 209. Technology Readiness Levels for biofuels.        357
• Table 210. Comparison of biofuels. 358
• Table 211. Comparison of biofuels and e-fuels to fossil fuels and electricity.     359
• Table 212. Classification of biomass feedstock.    359
• Table 213. Biorefinery Feedstocks.  360
• Table 214. Types of biofuel by generation.  361
• Table 215. Feedstock Conversion Pathways.            362
• Table 216. Biobased feedstock sources for ethanol.           363
• Table 217. Lignocellulosic ethanol plants and capacities.              365
• Table 218. Comparison of Pulping and Biorefinery Lignins.            366
• Table 219. Commercial and Pre-Commercial Biorefinery Lignin Production Facilities.                366
• Table 220.Operating and Planned Lignocellulosic Biorefineries. 367
• Table 221. Conventional biofuel types.         368
• Table 222. Biodiesel by Generation.                369
• Table 223. Biodiesel Production Techniques.           370
• Table 224. Biofuel Production Cost from the Biomass Pyrolysis Process.             371
• Table 225. Properties of Vegetable Oils in Comparison to Diesel.               372
• Table 226. Global Biodiesel Consumption 2010-2036 (Million litres/year).          373
• Table 227. Main producers of HVO and capacities.              373
• Table 228. Renewable diesel price ranges by region.          374
• Table 229. Example Commercial Development of BtL Processes.             375
• Table 230. Pilot or Demo Projects for Biomass to Liquid (BtL) Processes.             376
• Table 231. Global Renewable Diesel Consumption 2010-2036 (Million litres/year).      376
• Table 232. Renewable Diesel Price Ranges.              377
• Table 233. Advantages and disadvantages of bio-aviation fuel.   378
• Table 234. Advantages and Disadvantages of Bio-Aviation Fuel. 379
• Table 235. Production Pathways for Bio-Aviation Fuel.       380
• Table 236. Current and Announced Bio-Aviation Fuel Facilities and Capacities.             380
• Table 237. Global Bio-Jet Fuel Consumption 2019-2036 (Million litres/year).     381
• Table 238. Comparison of biogas, biomethane, and natural gas.               383
• Table 239. Biogas Feedstocks.           383
• Table 240. Existing and Planned Bio-LNG Production Plants.        385
• Table 241. Methods for Capturing Carbon Dioxide from Biogas. 386
• Table 242. Comparison of Different Bio-H₂ Production Pathways.             387
• Table 243. Markets and Applications for Biohydrogen.      388
• Table 244. Summary of Applications of Biochar in Energy.              389
• Table 245. Typical Composition and Physicochemical Properties for Bio-Oils. 389
• Table 246. Properties and Characteristics of Pyrolysis Liquids Derived from Biomass.               390
• Table 247. Main Techniques Used to Upgrade Bio-Oil into Higher-Quality Fuels.             391
• Table 248. Markets and Applications for Bio-Oil.   392
• Table 249. Bio-Oil Producers.             393
• Table 250. Properties of Microalgae and Macroalgae.        394
• Table 251. Yield of Algae and Other Biodiesel Crops.          395
• Table 252. Algae-Derived Biofuel Producers.            396
• Table 253. Addressable Market Size for Biofuels.  398
• Table 254. Risks and Opportunities in Biofuels.     399
• Table 255. Global Revenues for Biofuels by Type 2020-2036.       399
• Table 256. Global Revenues for Biofuels by Applications Market 2020-2036.    400
• Table 257. Global Revenues for Biofuels by Regional Market 2020-2036.             401
• Table 258. Market Growth Drivers and Trends in Biofuels.               401
• Table 259. Biofuels Regulations.       402
• Table 260. Value Chain: Biofuels.     403
• Table 261. Key players in biofuels.   404
• Table 262. Environmental Biotechnology Market Overview.            406
• Table 263. Bioremediation Technology Applications and Capabilities.   407
• Table 264. Applications of Synthetic Biology in Bioremediation. 409
• Table 265. Biological Wastewater Treatment Technologies.           410
• Table 266. Enzymes and Microbial Products for Wastewater Treatment.               411
• Table 267. Enzymatic Plastic Degradation Technologies. 413
• Table 268. Commercial and Development-Stage Plastic Biodegradation Initiatives.     414
• Table 269. Carbon Capture Integration Pathways for Biomanufacturing: Overview.      416
• Table 270. Economic Analysis of Carbon Capture Integration Pathways.              418
• Table 271. Biological Carbon Capture Technologies.          419
• Table 272. Key Companies in Biological Carbon Capture.               420
• Table 273. Air Biotreatment Technologies and Applications.         421
• Table 274. Air Biotreatment Applications by Industry.        422
• Table 275. Environmental Biotechnology Value Chain.      423
• Table 276. Regulatory Framework for Environmental Biotechnology.       424
• Table 277. Key Companies in Environmental Biotechnology.         425
• Table 278. Environmental Biotechnology Market Drivers and Trends.      426
• Table 279. Environmental Biotechnology Market Forecast (2024-2036).               427
• Table 280. Consumer Goods Biotechnology Market Overview.    428
• Table 281. Biotechnology Applications in Personal Care and Cosmetics.             430
• Table 282. Key Personal Care Biotechnology Ingredients.                431
• Table 283. Enzymes in Home Care Products.           432
• Table 284. Sustainable Ingredients for Home Care Products.       434
• Table 285. Home Care Enzyme Market by Application.      435
• Table 286. Biotechnology-Derived Fragrances and Flavours.         436
• Table 287. Major F&F Companies and Biotechnology Investments.          437
• Table 288. Biotechnology Applications in Textiles.                438
• Table 289. Bio-based Fiber and Material Producers.            439
• Table 290. Consumer Goods Biotechnology Value Chain.              440
• Table 291. Regulatory Framework for Consumer Goods Biotechnology. 441
• Table 292. Key Companies in Consumer Goods Biotechnology. 442
• Table 293. Consumer Goods Biotechnology Market Drivers.         442
• Table 294. Consumer Goods Biotechnology Market Forecast (2024-2036).        444
• Table 295. Total Addressable Market Summary by Sector (Billion USD)  446
• Table 296. Technology-Application Matrix   447
• Table 297. Technology Convergence Drivers and Timeline              448
• Table 298. Global Revenues for Synthetic Biology by Technology, 2020-2036 (Billion USD)      450
• Table 299. Precision Fermentation Products and Applications    451
• Table 300. Cell-Free vs Cell-Based Systems Comparison               453
• Table 301. AI-Driven Fermentation Platform Companies  454
• Table 302. Types of Fermentation Processes            454
• Table 303. Key Fermentation Parameter Comparison        455
• Table 304. Technology Platform Comparison Matrix            456
• Table 305. Global Revenues for Biopharmaceuticals by Application (2020-2036), Billions USD            457
• Table 306. Biopharmaceutical Market by Product Category           459
• Table 307. Global Revenues for Biopharmaceuticals by Region (2020-2036), Billions USD      459
• Table 308. Global Revenues for Industrial Enzymes (Billion USD)               460
• Table 309. Market Segmentation by Type of Industrial Enzymes 2023-2036 (Billion USD)          462
• Table 310. Market Segmentation by Source of Industrial Enzymes 2023-2036 (Billion USD)    463
• Table 311. Global Revenues for Biofuels by Type (2020-2036), Billions USD       463
• Table 312. Global Revenues for Biofuels by Application (2020-2036), Billions USD       465
• Table 313. Global Revenues for Biofuels by Region (2020-2036), Billions USD  466
• Table 314. Global Revenues for Bioplastics by Type (2020-2036), Billions USD 466
• Table 315. Types of PHAs and Properties     468
• Table 316. Global Revenues for Bioplastics by Application (2020-2036), Billions USD 468
• Table 317. Global Revenues for Bioplastics by Region (2020-2036), Billions USD           470
• Table 318. Global Revenues for Biochemicals by Type (2020-2036), Billions USD          470
• Table 319. Global Revenues for Biochemicals by Application (2020-2036), Billions USD           472
• Table 320. Global Revenues for Biochemicals by Region (2020-2036), Billions USD     473
• Table 321. Global Revenues for Bio-Agritech by Application (2020-2036), Billions USD              473
• Table 322. Global Revenues for Bio-Agritech by Region (2020-2036), Billions USD        475
• Table 323. Global Revenues for Synthetic Biology by Product Type, 2020-2036 (Billion USD)  476
• Table 324. Global Revenues for Synthetic Biology by Region, 2020-2036 (Billion USD) 477
• Table 325. White Biotechnology Revenues by Region, 2020-2035 (Billion USD) 477
• Table 326. Selected Major Investments in Synthetic Biology          478
• Table 327. Porter's Five Forces Analysis: Synthetic Biology and Biomanufacturing.      486
• Table 328. Feedstock Supplier Landscape and Characteristics. 489
• Table 329.Production Scale Economics.     490
• Table 330. End-User Segment Analysis.      491
• Table 331. Economic Viability Assessment Framework.   492
• Table 332. Scale-Up Cost Impact Analysis.              493
• Table 333. Market Map: Synthetic Biology and Biomanufacturing.            493
• Table 334.Competitive Positioning Matrix. 494
• Table 335.U.S. Regulatory Framework Summary.  500
• Table 336.EU Regulatory Framework Summary.    502
• Table 337.Asia-Pacific Regulatory Framework Comparison.         503
• Table 338. International Standards and Harmonization.  504
• Table 339. Biosafety and Biosecurity Framework. 505
• Table 340. Production Cost Breakdown by Product Type. 506
• Table 341. Scale-Up Factors and Mitigation Strategies.     508
• Table 342. Technical Challenge Assessment.          510
• Table 343. Feedstock Price Impact Analysis.           511
• Table 344. US Government Biotechnology Funding.            512
• Table 345. EU Bioeconomy Support Mechanisms.               514
• Table 346. Carbon Price Impact on Production Economics.          515
• Table 347. Lactips plastic pellets.    850
• Table 348. Oji Holdings CNF products.         945

List of Figures

• Figure 1. Key Market Metrics and Growth Projections 2026-2036.             69
• Figure 2. Technology Readiness and Commercial Maturity by Application Sector           72
• Figure 3. Global Synthetic Biology Market by Technology Segment 2026-2036 (USD Billion).. 73
• Figure 4. Global Synthetic Biology Market Growth 2020-2036      75
• Figure 5. Technology Convergence in Industrial Biomanufacturing           80
• Figure 6. AI/ML Applications Across Biomanufacturing Value Chain        89
• Figure 7. Technology Roadmap 2026-2028: Near-Term Developments   96
• Figure 8. Technology Roadmap 2029-2032: Mid-Term Developments      98
• Figure 9. Technology Roadmap 2033-2036: Long-Term Vision      100
• Figure 10. Industrial Biomanufacturing Value Chain Overview.    102
• Figure 11.Biomanufacturing Production System Overview.            114
• Figure 12. Evolution from Genetic Engineering to Synthetic Biology          116
• Figure 13. Timeline of Industrial Biotechnology Development       118
• Figure 14. Biopharmaceutical Manufacturing Value Chain             147
• Figure 15. Alternative Protein Production Pathways             152
• Figure 16. Life Cycle Assessment Framework for Bio-Based Products    158
• Figure 17. Precision Fermentation Market by Application 2024-2036 (USD Billion)        179
• Figure 18. Cell-Free Systems Market by Application 2024-2036 (USD Billion).  181
• Figure 19. Carbon Capture Integration Pathways for Biomanufacturing.               207
• Figure 20. Industrial Enzyme Market Forecast by Application 2024-2036 (USD Billion).              246
• Figure 21. Global revenues for biopharmaceuticals, by applications market (2020-2036), billions USD.                290
• Figure 22. Total Addressable Market Summary by Sector (Billion USD)   446
• Figure 23. Global Revenues for Synthetic Biology by Technology, 2020-2036 (Billion USD)       450
• Figure 24. Global Revenues for Biopharmaceuticals by Application (2020-2036), Billions USD.           458
• Figure 25. Global Revenues for Industrial Enzymes (Billion USD)                461
• Figure 26. Market Segmentation by Type of Industrial Enzymes 2023-2036 (Billion USD)           462
• Figure 27. Global Revenues for Biofuels by Type (2020-2036), Billions USD        464
• Figure 28. Global Revenues for Biofuels by Application (2020-2036), Billions USD        465
• Figure 29. Global Revenues for Bioplastics by Type (2020-2036), Billions USD 467
• Figure 30. Global Revenues for Bioplastics by Application (2020-2036), Billions USD  469
• Figure 31. Global Revenues for Biochemicals by Type (2020-2036), Billions USD           471
• Figure 32. Global Revenues for Biochemicals by Application (2020-2036), Billions USD            472
• Figure 33. Global Revenues for Bio-Agritech by Application (2020-2036), Billions USD               474
• Figure 34. SWOT Analysis: Industrial Biomanufacturing. 481
• Figure 35. SWOT Analysis: Precision Fermentation.             483
• Figure 36. SWOT Analysis: Cell-Free Systems.        484
• Figure 37. SWOT Analysis: AI-Designed Enzymes. 486
• Figure 38. Technology Readiness Level: Biopharmaceuticals.     496
• Figure 39. Technology Readiness Level: Industrial Enzymes.         497
• Figure 40. Technology Readiness Level: Biofuels. 498
• Figure 41. Technology Readiness Level: Bioplastics.          499
• Figure 42. Technology Readiness Level: Biochemicals.#  500
• Figure 43. Pluumo.     523
• Figure 44. Algiknit yarn.           534
• Figure 45. Jelly-like seaweed-based nanocellulose hydrogel.       536
• Figure 46. ANDRITZ Lignin Recovery process.          550
• Figure 47. Anpoly cellulose nanofiber hydrogel.     554
• Figure 48. MEDICELLU™.         555
• Figure 49. Asahi Kasei CNF fabric sheet.     572
• Figure 50. Properties of Asahi Kasei cellulose nanofiber nonwoven fabric.          572
• Figure 51. CNF nonwoven fabric.      573
• Figure 52. Roof frame made of natural fiber.             585
• Figure 53. Beyond Leather Materials product.          591
• Figure 54. BIOLO e-commerce mailer bag made from PHA.           602
• Figure 55. Reusable and recyclable foodservice cups, lids, and straws from Joinease Hong Kong Ltd., made with plant-based NuPlastiQ BioPolymer from BioLogiQ, Inc.          603
• Figure 56. Fiber-based screw cap.   624
• Figure 57: Celluforce production process. 650
• Figure 58: NCCTM Process.  650
• Figure 59: CNC produced at Tech Futures’ pilot plant; cloudy suspension (1 wt.%), gel-like (10 wt.%), flake-like crystals, and very fine powder. Product advantages include:  651
• Figure 60. formicobio™ technology. 658
• Figure 61. nanoforest-S.         662
• Figure 62. nanoforest-PDP.   662
• Figure 63. nanoforest-MB.     663
• Figure 64. sunliquid® production process. 669
• Figure 65. sunliquid® production process. 678
• Figure 66. CuanSave film.     682
• Figure 67. Celish.        684
• Figure 68. Trunk lid incorporating CNF.         686
• Figure 69. ELLEX products.   687
• Figure 70. CNF-reinforced PP compounds.               688
• Figure 71. Kirekira! toilet wipes.         688
• Figure 72. Color CNF.               689
• Figure 73. Rheocrysta spray.                701
• Figure 74. DKS CNF products.            701
• Figure 75. Domsjö process.  704
• Figure 76. Mushroom leather.              717
• Figure 77. CNF based on citrus peel.             719
• Figure 78. Citrus cellulose nanofiber.            719
• Figure 79. Filler Bank CNC products.             749
• Figure 80. Fibers on kapok tree and after processing.         751
• Figure 81.  TMP-Bio Process.               754
• Figure 82. Flow chart of the lignocellulose biorefinery pilot plant in Leuna.         755
• Figure 83. Water-repellent cellulose.             757
• Figure 84. Cellulose Nanofiber (CNF) composite with polyethylene (PE).             758
• Figure 85. PHA production process.               759
• Figure 86. CNF products from Furukawa Electric. 760
• Figure 87. AVAPTM process. 779
• Figure 88. GreenPower+™ process.  780
• Figure 89. Cutlery samples (spoon, knife, fork) made of nano cellulose and biodegradable plastic composite materials.               785
• Figure 90. Non-aqueous CNF dispersion "Senaf" (Photo shows 5% of plasticizer).        787
• Figure 91. CNF gel.     797
• Figure 92. Block nanocellulose material.    798
• Figure 93. CNF products developed by Hokuetsu.                798
• Figure 94. Marine leather products. 806
• Figure 95. Inner Mettle Milk products.           815
• Figure 96. Kami Shoji CNF products.              834
• Figure 97. Dual Graft System.             837
• Figure 98. Engine cover utilizing Kao CNF composite resins.         838
• Figure 99. Acrylic resin blended with modified CNF (fluid) and its molded product (transparent film), and image obtained with AFM (CNF 10wt% blended).        838
• Figure 100. Kel Labs yarn.      839
• Figure 101. 0.3% aqueous dispersion of sulfated esterified CNF and dried transparent film (front side).                844
• Figure 102. Light Bio Bioluminescent plants.           859
• Figure 103. Lignin gel.               860
• Figure 104. BioFlex process. 865
• Figure 105. Nike Algae Ink graphic tee.          866
• Figure 106. LX Process.           872
• Figure 107. Made of Air's HexChar panels. 875
• Figure 108. TransLeather.       877
• Figure 109. Chitin nanofiber product.            882
• Figure 110. Marusumi Paper cellulose nanofiber products.           883
• Figure 111. FibriMa cellulose nanofiber powder.    884
• Figure 112. METNIN™ Lignin refining technology.    889
• Figure 113. IPA synthesis method.   895
• Figure 114. MOGU-Wave panels.      899
• Figure 115. CNF slurries.        902
• Figure 116. Range of CNF products.               902
• Figure 117. Reishi.      908
• Figure 118. Compostable water pod.             929
• Figure 119. Leather made from leaves.         930
• Figure 120. Nike shoe with beLEAF™.              931
• Figure 121. CNF clear sheets.             945
• Figure 122. Oji Holdings CNF polycarbonate product.       946
• Figure 123. Enfinity cellulosic ethanol technology process.           971
• Figure 124.  Precision Photosynthesis™ technology.            978
• Figure 125. Fabric consisting of 70 per cent wool and 30 per cent Qmilk.             980
• Figure 126. XCNF.       991
• Figure 127: Plantrose process.           992
• Figure 128. LOVR hemp leather.         995
• Figure 129. CNF insulation flat plates.          998
• Figure 130. Hansa lignin.       1007
• Figure 131. Manufacturing process for STARCEL.  1015
• Figure 132. Manufacturing process for STARCEL.  1020
• Figure 133. 3D printed cellulose shoe.          1031
• Figure 134. Lyocell process. 1035
• Figure 135. North Face Spiber Moon Parka.              1044
• Figure 136. PANGAIA LAB NXT GEN Hoodie.             1044
• Figure 137. Spider silk production.  1045
• Figure 138. Stora Enso lignin battery materials.      1050
• Figure 139. 2 wt.％ CNF suspension.            1051
• Figure 140. BiNFi-s Dry Powder.         1052
• Figure 141. BiNFi-s Dry Powder and Propylene (PP) Complex Pellet.        1052
• Figure 142. Silk nanofiber (right) and cocoon of raw material.       1053
• Figure 143. Sulapac cosmetics containers.              1054
• Figure 144.  Sulzer equipment for PLA polymerization processing.            1055
• Figure 145. Solid Novolac Type lignin modified phenolic resins. 1056
• Figure 146. Teijin bioplastic film for door handles. 1068
• Figure 147. Corbion FDCA production process.     1084
• Figure 148. Comparison of weight reduction effect using CNF.    1085
• Figure 149. CNF resin products.        1091
• Figure 150. UPM biorefinery process.            1092
• Figure 151. Vegea production process.        1099
• Figure 152. The Proesa® Process.     1101
• Figure 153. Goldilocks process and applications. 1104
• Figure 154. Visolis’ Hybrid Bio-Thermocatalytic Process. 1108
• Figure 155. HefCel-coated wood (left) and untreated wood (right) after 30 seconds flame test.            1110
• Figure 156. Worn Again products.    1115
• Figure 157. XtalPi’s automated and robot-run workstations.         1119
• Figure 158. Zelfo Technology GmbH CNF production process.    1123

Purchasers will receive the following:

• PDF report download/by email. 
• Comprehensive Excel spreadsheet of all data.
• Mid-year Update

The Global Synthetic Biology & Biomanufacturing Market 2026-2036

PDF download/by email.

Payment methods: Visa, Mastercard, American Express, Paypal, Bank Transfer. To order by Bank Transfer (Invoice) select this option from the payment methods menu after adding to cart, or contact info@futuremarketsinc.com